Fortress Biotech Stock Performance
| FBIO Stock | USD 1.87 0.11 5.56% |
On a scale of 0 to 100, Fortress Biotech holds a performance score of 3. The firm shows a Beta (market volatility) of -1.25, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Fortress Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Fortress Biotech is expected to outperform it. Please check Fortress Biotech's maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to make a quick decision on whether Fortress Biotech's price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Fortress Biotech displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 178.3 M |
Fortress |
Fortress Biotech Relative Risk vs. Return Landscape
If you would invest 174.00 in Fortress Biotech on February 23, 2024 and sell it today you would earn a total of 13.00 from holding Fortress Biotech or generate 7.47% return on investment over 90 days. Fortress Biotech is currently generating 0.2242% in daily expected returns and assumes 4.8594% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Fortress, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Fortress Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fortress Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Fortress Biotech, and traders can use it to determine the average amount a Fortress Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0461
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FBIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.86 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Fortress Biotech is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fortress Biotech by adding it to a well-diversified portfolio.
Fortress Biotech Fundamentals Growth
Fortress Stock prices reflect investors' perceptions of the future prospects and financial health of Fortress Biotech, and Fortress Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fortress Stock performance.
| Return On Equity | -17.4 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (0.64) % | ||||
| Operating Margin | (2.81) % | ||||
| Current Valuation | 16.29 M | ||||
| Shares Outstanding | 19.92 M | ||||
| Price To Earning | (2.92) X | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 84.51 M | ||||
| EBITDA | (131.17 M) | ||||
| Cash And Equivalents | 208.35 M | ||||
| Cash Per Share | 1.92 X | ||||
| Total Debt | 88.59 M | ||||
| Debt To Equity | 1.24 % | ||||
| Book Value Per Share | 1.19 X | ||||
| Cash Flow From Operations | (128.22 M) | ||||
| Earnings Per Share | (6.03) X | ||||
| Total Asset | 167.53 M | ||||
| Retained Earnings | (694.87 M) | ||||
| Current Asset | 99.94 M | ||||
| Current Liabilities | 10.58 M | ||||
About Fortress Biotech Performance
To evaluate Fortress Biotech Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Fortress Biotech generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Fortress Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Fortress Biotech market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Fortress's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.Things to note about Fortress Biotech performance evaluation
Checking the ongoing alerts about Fortress Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fortress Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fortress Biotech may become a speculative penny stock | |
| Fortress Biotech had very high historical volatility over the last 90 days | |
| Fortress Biotech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 84.51 M. Net Loss for the year was (60.64 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech currently holds about 208.35 M in cash with (128.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 25.0% of the company shares are held by company insiders |
- Analyzing Fortress Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fortress Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Fortress Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fortress Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fortress Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fortress Biotech's stock. These opinions can provide insight into Fortress Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Fortress Stock analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Fortress Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.